2017
DOI: 10.1016/j.athoracsur.2017.06.060
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
21
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(22 citation statements)
references
References 13 publications
1
21
0
Order By: Relevance
“…Although Handa et al . reported that superior segment tumors had a higher incidence of mediastinal lymph node metastasis than basal segment tumors in patients with clinical stage I (clinical N0) lower lobe NSCLC, the difference was not significant . Tomizawa et al .…”
Section: Discussionmentioning
confidence: 93%
See 4 more Smart Citations
“…Although Handa et al . reported that superior segment tumors had a higher incidence of mediastinal lymph node metastasis than basal segment tumors in patients with clinical stage I (clinical N0) lower lobe NSCLC, the difference was not significant . Tomizawa et al .…”
Section: Discussionmentioning
confidence: 93%
“…10 Although Handa et al reported that superior segment tumors had a higher incidence of mediastinal lymph node metastasis than basal segment tumors in patients with clinical stage I (clinical N0) lower lobe NSCLC, the difference was not significant. 11 Tomizawa et al also reported that no significant difference existed in subcarinal or superior mediastinal lymph node metastasis between superior and basal segment tumors in the right lower lobe. 12 Our study showed that basal segment tumors had a significantly higher possibility of developing N2 lymph node metastasis than superior segment tumors in patients 3.574 2.109-6.058 < 0.001 †The hazard ratio (HR) associated with age is the increase in hazard associated with a one-year increase in age.…”
Section: Discussionmentioning
confidence: 94%
See 3 more Smart Citations